供给：5 月，医药行业生产动能有所下降。1～5 月， 医药行业工业增加值为 6.7%，增速较 1～4 月下降 0.5 个百分点。其 中，5 月医药行业工业增加值为 5.6%，增速较 4 月下降 3.5 个百分 点。需求：5 月，药品零售市场需求较为平稳，中西药品零售总额保 持稳定增长。1～5 月，中西药品零售总额为 2430.9 亿元，同比增长 11%，增速与 1～4 月持平。5 月，中西药品零售总额为 495 亿元， 同比增长 11.2%，环比增长 0.47%。 

The general view on biostimulants is that they are neither fertilizers nor pesticides, and are in some ways beneficial to the plant body. Given the urgent need to enhance the productivity of agricultural lands, this niche segment has been registering robust growth. Regional bodies, such as the European Biostimulant Industry Council (EBIC) and Biostimulant Coalition, have defined the segment to provide a clear picture.

As per the WHO, mHealth is defined as the medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistances, and other wireless devices. The US Food and Drug Administration (FDA) estimates that roughly 500 million people are already using personal healthcare ‘apps’ globally (mobile software applications). The definitions for individual segments have been provided in the respective segments. The market estimates provided in this report are entirely based on the segments of the United States mobile health market, which is covered in this report.

The global dietary supplement market (henceforth referred to as market studied) was valued at USD 101.38 billion in 2018 and is expected to attain a value of USD 151.57 billion in 2024, registering a CAGR of 6.9%, during the forecast period (2019-2024). The dietary supplements market is preliminarily driven by the paradigm shift toward preventive health management practices amid rising healthcare costs and increasing burden of lifestyle diseases. • Digitization in retail is expected to boost the future growth of dietary supplements. Moreover, the popularity of herbal supplements is also expected to drive the market growth in the future.

Cardiovascular Devices market is growing at a considerable rate, owing to factors, such as the rapid technological advances, increasing awareness of the population, high preference of minimally invasive procedures over conventional surgeries. The definitions for individual segments have been provided in the respective segments. The market estimates provided are entirely based on the segments tracked in this report and the estimates provided in this report may not be in line with other reports, where the segments tracked may not be in line with this report.

Diabetes has become one of the most common lifestyle diseases that affects the metabolism. As a result, the person experiences high glucose levels in blood, either because the beta cells do not produce insulin (type-1 diabetes) that is required for the breakdown of glucose, or the produced insulin is not utilized properly (type-2 diabetes). Approximately 10% of the diabetes, worldwide, contributes to type-1 diabetes and 90% contributes to type-2 diabetes. Type-1 patients need to take insulin throughout their life, along with maintaining a healthy diet and regular physical exercise. Type-2 patients need to eat healthy, be physically active, and take regular test to check their blood glucose level. They may also need to take oral medication and insulin to control the glucose levels in blood. Diabetes, as a condition, has many complications associated with it, including diabetic ketoacidosis and non-ketotic hyperosmolar coma. Serious long-term complications include heart disease, stroke, kidney failure, foot ulcers, and damage to the eyes.

Preoperative surgical planning is the preoperative procedure of pre-visualization of surgical interventions. This procedure is executed to predefine the surgical steps and to understand specific functions, for instance, to visualize bone segment repositioning in the context of the final surgery outcome. In this report, the global preoperative surgical planning software market is analyzed using the revenues generated by sales of different preoperative software currently available in the market. However, the report does not consider revenues generated by other healthcare IT software in the analysis.

The global prebiotic ingredient market was valued at USD 3847.14 million in 2018, and is expected to reach USD 7509.10 million by 2024, registering a CAGR of 12.2%, during the forecast period (2019-2024).Consumers have become increasingly knowledgeable about the importance of dietary fiber in maintaining a healthy digestive system and prefer a diet with increased fiber intake. Prebiotics are driving the digestive health ingredients market, with bakery and cereal products, expected to witness high demand.

Bariatric surgery or weight loss surgery is used as one of the major treatment procedures for treating obesity. It is generally the last option for patients who have failed in the attempt to lose weight with several other means. During this procedure, the size of the stomach is reduced by either removing some parts of the stomach or using a gastric band. The definitions for individual segments have been provided in the respective segments. The market estimates provided in this report are entirely based on the segments of the North America bariatric surgery market, which is covered in this report.

CAD, also known as coronary heart disease (CHD) or simply heart disease, develops when coronary arteries that supply blood, oxygen, and nutrients to the heart become damaged or diseased. Cholesterol-containing deposits (plaque formation) narrows the coronary arteries and decrease the blood flow to the heart, causing CAD. The decreased blood flow to the heart may cause angina and shortness of breath. Complete blockage of blood flow can lead to heart attack and permanent damage to the heart muscles. Further, over a period of time, CAD also weakens the heart muscles, leading to heart failure and abnormal heart rhythms called arrhythmias.

The distribution and manufacturing of insulin are carried out by very few multinational companies outside the recognized biosimilar manufactures, and a handful of small companies are developing insulin manufacturing abilities built upon up-to-date biotechnological methods, in turn, enhancing the growth and increasing the size of the insulin market. Biosimilars are estimated to cost 20-30% less than their originator drug. Therefore, they offer lower cost alternatives, with the potential to expand market competition and increase access to treatment. A recent report estimated that healthcare systems in the European Union (EU) could save up to USD 110 billion by using biosimilars. The ever rising number of producers who are developing biosimilar insulin may help deliver clinical aid, as compared to the ones currently available for insulin analogs, at a very affordable price.

Good nutrition is an important part of a healthy lifestyle. Nutrition also focuses on preventing or reducing diseases, conditions, and problems with a healthy diet. Combining physical activities and a nutritional diet can help to achieve and maintain a healthy weight, reduce the risk of chronic diseases (like heart disease, cancer, neurological and others), and promote overall health. The lack of proper nutrition due to unhealthy eating habits has adverse effects on health and cause diseases like diabetes, obesity, and other severe health issues.

The global algae omega-3 ingredients market is segmented based on the concentration type, application, product type, and geography. By concentration type, the algae omega-3 ingredients market is segmented into high concentrated, low concentrated, and medium concentrated. The algae omega-3 ingredients market, by application, is segmented into food and beverage, dietary supplements, pharmaceuticals clinical nutrition and animal nutrition. By type, it is segmented into eicosapentanoic acid (EPA), docosahexaenoic acid (DHA), and EPA/DHA.

The North America market for clinical nutrition is growing due to increasing prevalence of metabolic disorders and increased healthcare expenditure. Moreover the increasing health consciousness is also responsible to drive the growth of clinical nutrition market. Growing obese population levels due to unhealthy dietary habits, as well as physical inactivity, are expected to propel growth in the industry. According to CDC data, nearly 35% of American chi ldren consume junk food on a daily basis, in turn, leading to conditions, such as diabetes, obesity, and cardiovascular diseases. A majority of elderly people suffer from loss of appetite or digestive problems, requiring supply of nutrients through parenteral or enteral routes. These trends are thereby fueling market growth

Antacids are used for treating heartburn, soar stomach, acid indigestion, and upset stomach. They are helpful in protecting stomach, duodenum, and esophagus from the harsh acids that are primarily released while eating foods. It is better to take advice from a physician or a pharmacist, regarding the intake of antacids, in order to avoid side effects, especially when used in combination with other prescribed drugs.

本文根据新药研发的特点，结合典型案例详述了新药研发中的专利申请策略、基本专利策略和后续专利策略，希望有助于我国医药企业掌握相关专利策略，并能够熟练运用在新药研发中，促进中国医药产业的发展。

随着现代信息技术的发展，信息化、网络化、数字化的理念和应用已经逐渐融入社会生活的方方面面，医院这一重要领域也不例外。近几年来，我国医院信息化建设取得了长足进步，但是在信息化发展过程中仍然存在着一些弊端，如果不妥善对待将会阻碍医院的持续发展。该文从医院信息化建设的意义展开，主要探讨医院信息化建设面临的问题和应对策略。

该文简要综述了双向转诊模式在国内的应用现状，就双向转诊模式下的理论和实践做出归纳与总结，针对现阶段国内双向转诊模式中的群众知晓率低、转诊途径不畅、宣传力度较低、管理缺陷以及严重趋利因素等问题进行分析，并从双向转诊模式下的医联体建设以及临床路径管理两个研究方向进行分析，旨在为双向转诊制度在国内的推广与贯彻落实提供科学的参考借鉴。